(Q52042816)

20 April 2018

title

Alzheimer's disease. Short precursor shortens memory. (English)

1 reference

20 April 2018

author name string

Mattson MP

series ordinal

1

1 reference

20 April 2018

Furukawa K

series ordinal

2

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

20 April 2018

published in

Nature

1 reference

20 April 2018

volume

387

1 reference

20 April 2018

issue

6632

1 reference

20 April 2018

page(s)

457-458

1 reference

20 April 2018

https://scigraph.springernature.com/pub.10.1038/387457a0

exact match

0 references

cites work

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

7 January 2021

Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein.

1 reference

7 January 2021

Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein.

1 reference

7 January 2021

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

1 reference

7 January 2021

Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein.

1 reference

7 January 2021

Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation

1 reference

7 January 2021

Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain

1 reference

7 January 2021

An etiological role of amyloidogenic carboxyl-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease.

1 reference

7 January 2021

Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus

1 reference

7 January 2021

Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals.

1 reference

7 January 2021

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

1 reference

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

7 January 2021

Identifiers

DOI

10.1038/387457A0

1 reference

20 April 2018

Dimensions Publication ID

0 references

1 reference

20 April 2018